MammoVerse: Breast Cancer Sexual Health Focus Groups (NCT07644858) | Clinical Trial Compass
CompletedNot Applicable
MammoVerse: Breast Cancer Sexual Health Focus Groups
United States24 participantsStarted 2026-03-12
Plain-language summary
The purpose of this study is to explore the lived experiences, emotional challenges, and coping processes related to changes in sexual health and intimacy among women diagnosed with breast cancer. Insights gained from participants' personal experiences will provide a deeper understanding of patients' informational, emotional, and relational support needs, which will inform the development of an AI-driven digital support platform aimed at delivering personalized education, facilitating communication, and improving overall quality of life among women living with and beyond breast cancer in Florida.
The study involves focus group discussions conducted via Zoom and online questionnaires administered to breast cancer patients and survivors.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* female
* diagnosed with breast cancer (current patients and survivors);
* can provide informed consent;
* are self-reporting that they are emotionally (based on clinical questionnaires below) and
* are self-reporting that they are physically able to participate in a 60-minute group discussion.
Exclusion Criteria:
* prisoners
* unable to understand English and provide consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This MammoVerse study used tools like the Female Sexual Function Index and the Female Sexual Distress Scale — are those the same assessments you use to evaluate sexual health concerns in your breast cancer patients, and could we go through them together?
2Since this was a focus group study rather than a treatment trial, what has research like this taught us about the kinds of sexual health and intimacy challenges I might face during or after breast cancer treatment, and how do you typically address them?
3The study focused specifically on women's experiences of sexual functioning and distress after a breast cancer diagnosis — is sexual health something we should be proactively monitoring as part of my care plan, or do most patients wait until problems come up?
4Are there currently any treatment trials or support programs for breast cancer-related sexual health that you'd recommend I look into, now that studies like this one have helped build a better understanding of the issue?
5If I do experience sexual health changes as a result of my diagnosis or treatment, what specialists — like a pelvic health therapist or sexual health counselor — would you refer me to, and how soon should I bring up concerns?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Qualitative Foundation for Understanding Sexual Health and Intimacy Experiences of Women Diagnosed with Breast Cancer during Focus Group Discussion.
Timeframe: 3 months
2
Sexual functioning assessment using Female Sexual Function Index (FSFI)
Timeframe: 3 Months
3
Sexual Distress Assessment using Female Sexual Distress Scale Revised (FSDS R)